ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,200Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 1479

$403K Total Retail Price of All Prescriptions

Rank: 82 out of 1479

549 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 9,729 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 880 640 1 1
RANITIDINE HCL 599 455 2 4
ENALAPRIL MALEATE 461 452 3 3
GLIPIZIDE 460 352 4 13
METFORMIN HCL 374 289 5 2
FUROSEMIDE 334 287 6 15
OMEPRAZOLE 322 265 7 7
LEVOTHYROXINE SODIUM 314 273 8 9
CILOSTAZOL 297 250 9 65
GABAPENTIN 296 200 10 5
SYNTHROID 197 168 11 12
NAPROXEN SODIUM 195 161 12 87
INSULIN SYRINGE 194 165 13 30
ATENOLOL 176 97 14 11
LISINOPRIL 175 155 15 16
LOSARTAN POTASSIUM 174 174 16 8
CAPTOPRIL 173 99 17 28
EVISTA 153 127 18 79
NABUMETONE 137 110 19 22
TRAMADOL HCL 134 115 20 20
ZOLPIDEM TARTRATE 133 110 21 23
METOPROLOL TARTRATE 132 131 22 17
DONEPEZIL HCL 131 131 23 45
PHENYTOIN SODIUM EXTENDED 131 107 23 132
CIPROFLOXACIN HCL 129 98 25 26
SILVER SULFADIAZINE 120 112 26 130
AZITHROMYCIN 106 75 27 25
CLOPIDOGREL 105 97 28 46
OXYCODONE-ACETAMINOPHEN 101 0 S2 29 70
AMLODIPINE BESYLATE 97 87 30 6
MECLIZINE HCL 94 91 31 50
LANTUS 93 63 32 35
HUMULIN 70-30 90 75 33 43
CARBIDOPA-LEVODOPA 90 90 33 184
DIGOXIN 86 86 35 61
CARVEDILOL 85 83 36 32
HUMULIN N 80 74 37 42
POTASSIUM CHLORIDE 79 60 38 311
NAMENDA 79 78 38 69
PERMETHRIN 74 57 40 200
PLAVIX 74 67 40 52
CIMETIDINE 72 71 42 178
CLOTRIMAZOLE-BETAMETHASONE 70 54 43 39
LOSARTAN-HYDROCHLOROTHIAZIDE 70 69 43 14
LACTULOSE 64 57 45 172
ISOSORBIDE MONONITRATE ER 63 63 46 31
PREDNISONE 62 38 47 67
DOXAZOSIN MESYLATE 62 57 47 33
VERAPAMIL ER 58 58 49 34
LEVOXYL 56 49 50 44
GLIPIZIDE ER 56 51 50 110
WARFARIN SODIUM 55 40 52 83
SERTRALINE HCL 55 54 52 38
AMLODIPINE BESYLATE-BENAZEPRIL 54 44 54 54
ISOSORBIDE DINITRATE 53 50 55 82
HYDROCHLOROTHIAZIDE 53 52 55 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.